The present invention relates to compounds Formula (I): as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections. ##STR00001##

 
Web www.patentalert.com

< Pyrazolyl and imidazolyl pyrimidines as CRF antagonists

> Methods to modulate conditions mediated by the CXCR4 receptor
~ 00455